TuHURA Biosciences, Inc.
HURA
$1.81
-$0.03-1.63%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.96M | 5.99M | 5.73M | 4.31M | 3.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.42M | 22.42M | 20.06M | 17.65M | 14.61M |
| Operating Income | -25.42M | -22.42M | -20.06M | -17.65M | -14.61M |
| Income Before Tax | -29.29M | -27.76M | -23.50M | -21.68M | -18.37M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -29.29 | -27.76 | -23.50 | -21.68 | -18.37 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.29M | -27.76M | -23.50M | -21.68M | -18.37M |
| EBIT | -25.42M | -22.42M | -20.06M | -17.65M | -14.61M |
| EBITDA | -25.35M | -22.34M | -19.96M | -17.53M | -14.48M |
| EPS Basic | -0.65 | -1.05 | -1.27 | -1.51 | -1.41 |
| Normalized Basic EPS | -0.35 | -0.55 | -0.74 | -0.89 | -0.83 |
| EPS Diluted | -0.65 | -1.05 | -1.27 | -1.51 | -1.41 |
| Normalized Diluted EPS | -0.35 | -0.55 | -0.74 | -0.89 | -0.83 |
| Average Basic Shares Outstanding | 180.95M | 142.46M | 110.09M | 78.85M | 104.54M |
| Average Diluted Shares Outstanding | 180.95M | 142.46M | 110.09M | 78.85M | 104.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.02% | -0.02% | -0.01% | -- | -- |